A detailed insight to the successes of the SteriPlas Cold Plasma medical device which boasts an extensive bibliography of clinical trials and studies to date. The SteriPlas is widely used across the UK and EU for the management of chronic infections in wounds, surgical site infections and medical dermatology conditions.

The dense Cold Plasma produced from the SteriPlas results in a total destruction of multi-resistant bacteria often protected within biofilm, all whilst being harmless to mammalian cells. The SteriPlas has been widely documented in clinical studies as being effective against non-healing wound conditions where conventional therapies such as an antibiotics have failed to heal. The result is a significant reduction in bed occupancy and financial burden to the hospital as the accelerated healing properties allow patients to heal faster and be discharged from urgent care.

Speaker: Jeiram Jeyaratnam, Business Development Manager, Adtec Healthcare

• Experienced business development professional with 10+ years of experience in healthcare and hospital settings
• Extensive knowledge and experience in the wound care, surgical site infection, and medical dermatology markets.
• Proven ability to identify and develop new business opportunities in key markets.
• Leads setting up the core network of early adopters, KOLs, and distributors for AHL. 

 Location: UK Presentation Theatre: Hall 16, J48